Cargando…
Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa
Retinitis pigmentosa (RP) is an inherited retinal dystrophy that courses with progressive degeneration of retinal tissue and loss of vision. Currently, RP is an unpreventable, incurable condition. We propose glycogen synthase kinase 3 (GSK-3) inhibitors as potential leads for retinal cell neuroprote...
Autores principales: | Marchena, Miguel, Villarejo-Zori, Beatriz, Zaldivar-Diez, Josefa, Palomo, Valle, Gil, Carmen, Hernández-Sánchez, Catalina, Martínez, Ana, de la Rosa, Enrique J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009897/ https://www.ncbi.nlm.nih.gov/pubmed/28114834 http://dx.doi.org/10.1080/14756366.2016.1265522 |
Ejemplares similares
-
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
por: Sánchez-Cruz, Alonso, et al.
Publicado: (2018) -
Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa
por: Sánchez-Cruz, Alonso, et al.
Publicado: (2022) -
p75(NTR) antagonists attenuate photoreceptor cell loss in murine models of retinitis pigmentosa
por: Platón-Corchado, María, et al.
Publicado: (2017) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis
por: Zheng, Hanxue, et al.
Publicado: (2020)